IGHE and allergic bronchopulmonary aspergillosis: Other clinical scenarios in which anti-IgE treatment shows promise include chronic rhinosinusitis,[71] nasal polyposis,[72] chronic urticaria,[73,74] idiopathic angioedema,[75] eosinophil-associated gastrointestinal disorders,[76] mastocytosis,[69,77] latex allergy,[78] and allergic bronchopulmonary aspergillosis [79].